Jeremy Luban

Citée par

	Toutes	Depuis 2019
Citations	23761	6971
indice h	81	45
indice i10	152	119

1800

900

450

1350

1994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024136 183 286 351 376 326 374 361 431 430 658 668 754 879 753 729 891 1003 995 1112 1060 901 916 828 893 885 1254 1751 1457 1238 371

Accès public

Tout afficher

111 articles

1 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Stephen P. GoffProfessor of Biochemistry and Molecular Biophysics, Columbia UniversityAdresse e-mail validée de cumc.columbia.edu
Thomas PertelAllogene TherapeuticsAdresse e-mail validée de allogene.com
leonid yurkovetskiyUniversity of Massachusetts Medical SchoolAdresse e-mail validée de umassmed.edu
Jacob LemieuxThe Broad InstituteAdresse e-mail validée de broadinstitute.org
Douglas BraatenAnnals of the New York Academy of SciencesAdresse e-mail validée de nyas.org
John D ColganUniversity of IowaAdresse e-mail validée de uiowa.edu
James B. MunroUniversity of Massachusetts Chan Medical SchoolAdresse e-mail validée de umassmed.edu
Lionel BerthouxUniversité du Québec à Trois-RivièresAdresse e-mail validée de uqtr.ca
Stephen SchaffnerSenior Computational Biologist, Broad InstituteAdresse e-mail validée de broadinstitute.org
CIMARELLIPermanent Staff Research Director, INSERM U1111, ENS-Lyon, CNRSAdresse e-mail validée de ens-lyon.fr
Federico SantoniUniversity Hospital of LausanneAdresse e-mail validée de chuv.ch
Shawn B EgriUniversity of Massachusetts Medical SchoolAdresse e-mail validée de umassmed.edu
Martha R. NeaguMassachusetts General HospitalAdresse e-mail validée de mgh.harvard.edu
Yetao WangPost-doctor Molecular Biology, University of Massachusetts Medical SchoolAdresse e-mail validée de umassmed.edu
Pradeep UchilYale UniversityAdresse e-mail validée de yale.edu
Kuang ShenAssistant Professor, UMass Medical SchoolAdresse e-mail validée de umassmed.edu
Kyusik KimTessera TherapeuticsAdresse e-mail validée de tesseratx.com
Christian ReinhardBÜHLMANN Laboratories AGAdresse e-mail validée de buhlmannlabs.ch
Walther MothesYale School of MedicineAdresse e-mail validée de yale.edu
Mohammed AsmalOrbiMed AdvisorsAdresse e-mail validée de orbimed.com

Suivre

Jeremy Luban

UMass Med, Broad Institute of MIT and Harvard, Ragon Institute of MGH, MIT, & Harvard; MassCPR

Adresse e-mail validée de umassmed.edu - Page d'accueil

Virology Molecular Biology Immunology


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B J Luban, KL Bossolt, EK Franke, GV Kalpana, SP Goff Cell 73 (6), 1067-1078, 1993	1158	1993
Specific incorporation of cyclophilin A into HIV-1 virions EK Franke, HEH Yuan, J Luban Nature 372 (6504), 359-362, 1994	1088	1994
Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant L Yurkovetskiy, X Wang, KE Pascal, C Tomkins-Tinch, TP Nyalile, Y Wang, ... Cell 183 (3), 739-751. e8, 2020	1024	2020
Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1 DM Sayah, E Sokolskaja, L Berthoux, J Luban Nature 430 (6999), 569-573, 2004	859	2004
The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest JL Dunaief, BE Strober, S Guha, PA Khavari, K Ålin, J Luban, ... Cell 79 (1), 119-130, 1994	812	1994
TRIM5 is an innate immune sensor for the retrovirus capsid lattice T Pertel, S Hausmann, D Morger, S Züger, J Guerra, J Lascano, ... Nature 472 (7343), 361-365, 2011	744	2011
HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation A Rosa, A Chande, S Ziglio, V De Sanctis, R Bertorelli, SL Goh, ... Nature 526 (7572), 212-217, 2015	505	2015
Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors GJ Towers, T Hatziioannou, S Cowan, SP Goff, J Luban, PD Bieniasz Nature medicine 9 (9), 1138-1143, 2003	500	2003
Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription D Braaten, EK Franke, J Luban Journal of virology 70 (6), 3551-3560, 1996	486	1996
Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B F Re, D Braaten, EK Franke, J Luban Journal of virology 69 (11), 6859-6864, 1995	470	1995
TCR stimulation with modified anti-CD3 mAb expands CD8⁺ T cell population and induces CD8⁺CD25⁺ Tregs B Bisikirska, J Colgan, J Luban, JA Bluestone, KC Herold The Journal of clinical investigation 115 (10), 2904-2913, 2005	431	2005
Cyclophilin A regulates HIV‐1 infectivity, as demonstrated by gene targeting in human T cells D Braaten, J Luban The EMBO journal, 2001	382	2001
Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication. WC Van Voorhis, J Valinsky, E Hoffman, J Luban, LS Hair, RM Steinman The Journal of experimental medicine 158 (1), 174-191, 1983	378	1983
HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation B Mangeat, G Gers-Huber, M Lehmann, M Zufferey, J Luban, V Piguet PLoS pathogens 5 (9), e1000574, 2009	377	2009
Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein T Dorfman, J Luban, SP Goff, WA Haseltine, HG Göttlinger Journal of virology 67 (10), 6159-6169, 1993	370	1993
AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis C Cande, N Vahsen, I Kouranti, E Schmitt, E Daugas, C Spahr, J Luban, ... Oncogene 23 (8), 1514-1521, 2004	364	2004
TRIM5α selectively binds a restriction-sensitive retroviral capsid S Sebastian, J Luban Retrovirology 2, 1-3, 2005	329	2005
Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics A Kaul, S Stauffer, C Berger, T Pertel, J Schmitt, S Kallis, M Zayas Lopez, ... PLoS pathogens 5 (8), e1000546, 2009	304	2009
Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity E Sokolskaja, DM Sayah, J Luban Journal of virology 78 (23), 12800-12808, 2004	304	2004
Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA A Cimarelli, S Sandin, S Höglund, J Luban Journal of virology 74 (7), 3046-3057, 2000	270	2000

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs